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ABSTRACT 
Objective: To determine analgesic and anti-inflammatory activity of a oily formulation containing camphor, menthol and thymol as ingredients in 
wistar albino mice and rats. 
Methods: Acute toxicity studies were done as per OECD 423 guidelines. No signs of toxicity were observed up to 2000 mg/kg. Based on the 
mortality rate dose was designed. Analgesic activity was performed in Swiss albino mice by Hot plate method. Anti inflammatory activity was 
performed in male Wistar rats by turpentine induced inflammation model. 
Results: The formulation at a dose of (100 mg/kg & 200 mg/kg) produced a dose dependent significant analgesic effect in hot plate method (p<0.001). 
However the formulation at a dose of (250 mg/kg & 500 mg/kg) showed anti-inflammatory effect (p<0.001) when compared with the control group. 
Conclusion: In the above investigations OFCMT (oily formulation of camphor, menthol and thymol) has shown tremendous protection from pain 
and Inflammation in experimental animals the above pharmacological effects may be due to the presence of monoterpenoids in the formulation. 
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INTRODUCTION 
Herbal medicine has been used since ancient era for many centuries. 
In today’s life there is need for efficacious therapy for pain and 
inflammation. In the search for new therapeutic options, novel bio-
molecules of natural sources are to be investigated. Purpose of this 
study was to evaluate the analgesic and anti-inflammatory effects of 
OFCMT (Oily formulation of camphor, menthol and thymol).  
One of the important and effective parts of herbal plants is essential 
oil and substances present in different parts of plants. Essential oils 
are components which are oil soluble that have effective smell and 
aroma and are separated by use of water and steam distillation and 
prepared by extraction with solvents and enzymatic hydrolysis [1]. 
Likewise OFCMT of oily nature is the combination of the three active 
ingredients (camphor, menthol and thymol), which was emulsified 
using excipients. The excipients used to solubilize drugs in oral and 
injectable dosage forms include pH modifiers, organic solvents, 
surfactants, water-insoluble organic solvents, triglycerides and 
phospholipids. The solvent system chosen was able to solubilize the 
drug at the desired concentration and an environment was provided 
where the drug has sufficient chemical stability. Each active 
individual ingredient of OFCMT has its own medicinal value. 
Camphor, a natural product derived from the wood of the tree 
Cinnamomum camphora, has a long history of use as antiseptic, 
analgesic, antipruritic, counter irritant and rubefacient [2]. Menthol 
is a natural compound of plant origin known to produce cool 
sensation. Menthol, the cooling natural product of peppermint, is 
widely used preparations for pain relief in sports injuries, arthritis, 
and other painful conditions. Thymol is a natural monoterpene 
phenol derivative cymene, isomeric with carvacrol, found in oil of 
thyme, and extracted from Thymus vulgaris and various other kinds 
of plants as a white crystalline substance of a pleasant 
aromatic odor and strong antiseptic properties [3].  
However, limited information is available on the pharmacological 
properties of the above individual ingredients and mixture of the 
above in the form of formulation. There is no scientific report on the 
analgesic and anti-inflammatory effects of the above formulation to 
best of our knowledge. Based on the above claims, the present study is 
undertaken to evaluate analgesic and anti-inflammatory effect of the 
formulation. 
MATERIALS AND METHODS 
Oily formulation containing Camphor, Menthol and Thymol in 1:1:1 
w/w ratio was provided by Limra Pharmaceuticals, Hyderabad as a 
gift sample. 
Experimental animals 
Healthy wistar albino rats weighing about (120-160 gm) and mice 
weighing about (50-60 gm) of either sex were obtained from animal 
house. The animals were maintained under standard conditions i.e., 
housed in polypropylene cages and maintained at a temperature 
27±2 °C, relative humidity 65±10% under 12 hour light and dark 
cycle. The animals were acclimatized for 10 d in the animal house 
approved by the Animal ethical committee bearing registration 
No.1534/PO/A/11/CPCSEA, Anwar-ul-Uloom College of Pharmacy 
before carrying out the work. 
Chemicals 
Tween 80, cyclodextrin, Dimethyl Sulfoxide were obtained from 
Virchow Biotech Pvt Ltd. Turpentine oil, distilled water, and 
standard drugs diclofenac sodium and indomethacin (Ranchem 
Pharmaceuticals, Hyderabad)were obtained from the Drug store, 
Anwarul-Uloom College of Pharmacy, New Mallepally, Hyderabad.  
Solubilization of OFCMT 
Different solubilizing agents such as Dimethyl sulphoxide, Ethanol, 
Cyclodextrin, Hydroxypropyl methyl cellulose, Carboxymethyl 
Cellulose
Acute oral toxicity study was performed as per OECD-423 guidelines 
category IV (acute toxic class method). Male wistar albino rats (n=3) 
selected by random sampling technique were employed in this 
study. The animals were kept on fasting for 4 h with free access to 
clean drinking water only. 
 were used to solubilize the formulation. Finally fruitful 
results were obtained by adding tween 80 as surfactant. 12% of 
tween 80 was prepared in distilled water i.e. 12 gm of tween 80 was 
added to 88 gm of distilled water & stirred for 1 hour. OFCMT was 
added to the above solution in 1: 10 ratio with continuous stirring 
for 15 min. 
Method of determination of acute toxicity 
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The formulation was administered orally with maximum dose of 
2000 mg/kg body weight by oral feeding needle. The mortality was 
observed for three days. If mortality was observed in 2 out of 3 
animals or 3 out of 3 animals then the dose administered was 
assigned as toxic dose. If mortality was observed in 1 animal, then 
the same dose was repeated again to confirm the toxic dose. If 
mortality was not observed, the procedure was repeated for further 
higher dose such as 3000 mg/kg of body weight [4]. 
Statistical analysis 
The data was expressed as mean±SEM analyzed statistically using 
one way ANOVA procedures followed by Dunnett’s test, P-
value<0.005 was regarded as significant. P value<0.01 regarded as 
less significant and P-value<0.001 as highly significant. 
Evaluation of analgesic activity 
In the present investigation, analgesic activity of OFCMT was studied 
by using Eddy’s hot plate method using diclofenac sodium as 
standard drug. 
Hot plate induced analgesia [5] 
The animals were placed individually in hot plate regulated at a 
temperature (55±2 °C) before the treatment and its reaction time 
was determined. After noting the initial reaction time, the treatment 
was given to each mouse. Then the mice were placed on the Eddy’s 
hot plate under regulated temperature and the licking of the 
forepaws was recorded as the hot plate latency with the help of a 
stop-watch. The reaction time was re-determined after 0, 30, 60, 90 
& 120 min after oral administration of standard and test drug. 
The mice were divided into four groups with (n=6) and treated with 
the respective solutions as given below 
Group-I: served as control & received 12% tween 80 in distilled 
water as vehicle at a dose of 10 ml/kg body weight orally. 
Group-II: served as standard & received diclofenac sodium in 
distilled water at a dose of 50 mg/kg body weight orally. 
Group-III: served as Test1 & received test drug 100 mg/kg body 
weight orally. 
Group-IV: served as Test 2 & received test drug 200 mg/kg body 
weight orally. 
Evaluation of anti-inflammatory activity 
The anti inflammatory activity of FCMT was determined by 
turpentine induced inflammation [5, 6]. In this model, acute 
inflammation was induced by sub-plantar injection of 0.1 ml of 
turpentine oil one hour after oral administration of test drug at a 
dose of 250 & 500 mg/kg body weight, Indomethacin 10 mg/kg 
body weight, p. o and vehicle solution of 12% tween 80 in distilled 
water 10 ml/kg body weight, p. o. The volume of paw was 
determined at 0 h, pre and post treatment of turpentine oil, 1, 2, 3 
and 4 h following the injection of turpentine oil. The changes in the 
volume of paw were measured by a plethismometer. 
The rats were divided into four groups with (n=6) and treated with 
the respective solutions as given below. 
Group-I: served as control & received 12% tween 80 in distilled 
water as vehicle at a dose of 10 ml/kg body weight orally. 
Group-II: served as standard & received indomethacin in distilled 
water at a dose of 10 mg/kg body weight orally. 
Group-III: served as Test1 & received test drug 250 mg/kg body 
weight orally. 
Group-IV: served as Test2 & received test drug 500 mg/kg body 
weight orally. 
RESULTS 
Results of analgesic activity 
Hot plate model 
From the results of analgesic activity obtained it was observed that 
in the hot plate model the test group I i.e. OFCMT at a dose of 100 
mg/kg showed an increase in the reaction time after 30 min of 
administration (2.98±0.41) when compared with the initial value 
(1.61±0.41) as shown in the table 1 and fig. no1. In 60 min the 
reaction time in the same group increased gradually (4.18±0.33) 
again when compared with the initial value. In 90 min the reaction 
time of group I increased gradually (4.80±0.22) when compared 
with initial value likewise after 120 min the reaction time of group I 
increased gradually (5.56±0.24) again when compared with the 
initial value. In 240 min the reaction time of OFMCT (Test 1) group 
increased (6.28±0.22) and was at the peak, slightly closer to the 
standard group as seen in the table.1. From the above results it was 
evident that OFCMT Test I group which received 100 mg/kg of 
OFCMT showed a highly significant analgesic effect (p value 0.001) 
in 240 min and the effect was slightly significant in 30, 60, and 90 
and significant in 120 and 240 min. 
In the Test II group i.e. OFCMT (200 mg/kg) there was a gradual 
increase in the reaction time after 30 min of administration 
(2.15±0.30) when compared with the initial (1.81±0.20). In 60 min 
the OFCMT in Test II showed an increase in reaction time again 
(3.58±0.31). In 90 min the reaction time of Test II group showed an 
gradual increase in the reaction time (4.45±0.29). The reaction time 
slightly increased in 120 min (5.26±0.29) when compared to initial. In 
240 min the reaction time of (Test II) group increased (5.75±0.34) and 
was slightly closer to the standard group as seen in the fig no 1. From 
the above results it was evident that OFCMT Test II group which 
received 200 mg/kg of OFCMT showed a highly significant analgesic 
effect (p value 0.001) in 240 min and the effect was slightly significant 
in 30, 60, and 90 min and significant in 120 min and 240 min. 
Results of anti-inflammatory activity 
Turpentine induced inflammation  
From the results of anti inflammatory activity it was observed that 
at 1 h after administration of OFCMT at a dose of 250 mg/kg in the 
test group–I, the paw volume of rats was (0.48±0.03) showed an 
significant decrease in inflammation when compared with initial 
paw volume at 0 h (0.55±0.02). In 4 h the paw volume of rats was 
(0.39±0.01) which showed a significant decrease in paw volume 
animals compared to standard group as seen in table 2. 
In the test group II i. e OFCMT 500 mg/kg there was a gradual 
decrease in paw volume after 1h of administration of OFCMT when 
compared to initial paw volume at 0h (0.51±0.01) which showed a 
significant decrease in inflammation. In 4 h after administration paw 
volume was (0.41±0.02) which showed a significant decrease in paw 
volume of animals when compared to standard group. 
  
Table1: Analgesic activity in mice using hot plate method at different intervals of time 
Treatment group Dose(mg/kg) Reaction time in minutes (mean±SEM) 
initial 30 60 90 120 240 
Control 10 ml/kg 1.46±0.11 1.80±0.11 2.21±0.12 1.75±0.14 2.62±0.15 2.11±0.10 
Diclofenac  sodium 50 mg/kg 1.81±0.20 2.15±0.30 4.39±0.20 6.02±0.15** 8.10±0.12** 8.50±0.30*** 
Test-1 100 mg/kg 1.61±0.41 2.98±0.41 4.18±0.33 4.80±0.22** 5.56±0.24** 6.28±0.22*** 
Test-2 200 mg/kg 1.83±0.23 2.65±0.31 3.58±0.31 4.45±0.29** 5.26±0.29** 5.75±0.34*** 
**P<0.01: Significant, All the values are mean±SEM, n=6. One way ANOVA followed by Dunnets multiple comaparison test, ***p<0.001(INITIAL vs 
TEST I & TEST II) considered as extremely significant. 
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Table 2: Paw volumes of rats in different experimental groups 
TreatmentGroup Dose(mg/kg) Decrease in paw volume of rats (in hs) 
0h 1h 2h 3h 4h 
Control 5 ml/kg 0.50±0.01 0.48±0.01 0.47±0.02 0.46±0.01 0.45±0.01 
Indomethacin  10 mg/kg 0.76±0.02 0.62±0.01 0.57±0.01* 0.51±0.02** 0.49±0.01** 
Test-1 250 mg/kg 0.55±0.02 0.48±0.03 0.44±0.02* 0.41±0.02** 0.39±0.01** 
Test-2 500 mg/kg 0.51±0.01 0.48±0.01 0.46±0.02* 0.44±0.02** 0.41±0.02** 
*P<0.01: Lesssignificant, All the values are mean±SEM, n=6. One way Analysis of Variance (ANOVA) followed by Dunnets multiple comaparision test, 
**p<0.01(Initial vs. test I & test II) considered as significant 
 
DISCUSSION 
Considering that the relief of painful symptoms typically involve 
pharmacotherapy and there are hundreds of essential oils that have 
not been assessed, which continue to be major source of bioactive 
compounds used in pain and inflammatory conditions the present 
investigation was carried out [7]. 
In order to solubilize OFCMT, several solvents were tested and it 
was found that in Tween 80 the solubility was good. Therefore it 
was used as solvent there are many useful solvents in laboratory 
which are toxic to biological organisms and consequently interfere 
with the activity being studied [8].  
In order to demonstrate the effect of the tween 80, used for dispersion 
of OFCMT on the results of biological tests, a comparative study was 
carried out by administering 12% tween 80 to control group and test 
group which was treated with OFCMT dissolved in tween80. 
Acute toxicity studies indicated that doses up to 2000 mg/kg were 
safe following oral administration in rats, where as in mice doses up 
to 1000 mg/kg were safe. Based on this study 250 and 500 mg/kg 
were used for the evaluation of anti inflammatory activity in rats 
and 100 mg/kg and 200 mg/kg were used for evaluation of analgesic 
activity in mice. Analgesic activity was performed by hot plate 
method. The significant reduction in reaction time of mice in hot 
plate model suggests its centrally mediated analgesic activity. 
Cholinergic system is also one of important mechanism which 
interferes in modulation of pain. Pain is considered as an unpleasant 
sensation which usually involves a protective mechanism for the 
body which occurs whenever any tissue is damaged [9]. The 
significant reduction in reaction time of mice in hotplate model 
suggests its centrally mediated analgesic activity [10]. The 
evaluation of central analgesic activity though hotplate test was 
selected due to several advantages such as sensitivity to strong 
antinociceptive and limited tissue damage [11]. 
Inflammation is a complex pathophysiological response to different 
stimuli. It can be treated and resolved by acting on the different 
mediators, enzymes, and pathways implicated in the process. [12] 
The inflammatory process occurs as a defensive response, which 
induces profound physiological adaptations triggered in an attempt 
to limited tissue damage and removes the pathogenic insult [13]. By 
activating the enzyme cyclooxygenase, the levels of prostaglandins, 
especially PGE2, increases markedly and its production provokes 
inflammation [14], pain and fever [15]. Turpentine induced edema 
was used as an experimental animal model for acute inflammation 
and is believed to be biphasic. The early phase (1-2h) of the 
turpentine induced inflammation model is mainly mediated by 
histamine, serotonin and increased synthesis of prostaglandins in 
the surrounding damaged tissue. The late phase is sustained by 
bradykinin, leukotrienes, polymorphonuclear cells and 
prostaglandins produced by tissue macrophages. Since OFCMT 
significantly inhibited paw oedema induced by turpentine in the 
second phase, these findings suggests a possible inhibition of 
cyclooxygenase synthesis by OFCMT and this effect is similar to that 
produced by non steroidal inflammatory drugs such as 
indomethacin.  
Literature review evidenced the medicinal significance of 
monoterpenoids like menthol and thymol which were the 
constituents of OFCMT. Hence it can also be suggested that the 
analgesic and anti inflammatory activity of OFCMT might be due to 
the presence of monoterpenoids [16].  
As OFCMT showed tremendous protection from pain and 
inflammation in experimental animal models. The study can be 
further extended for clinical trials and attempt can be made for the 
patency of the same. 
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